Healing Centered

Tech Enabled

We See a Bright 
Future for Mental 
Health & Wellbeing

Interest in novel mental health solutions, including
psychedelic-assisted therapy, has greatly increased as research studies confirm their power and healing capabilities.

Yet, the enduring and efficacious results of these treatments
are not met by merely giving patients a drug.

What’s needed is therapeutic support to guide patients before,
during, and after their experiences.

PsyAssist leverages the power of cutting-edge technology, innovation, and science to support those undergoing 
treatment in a clinical setting.

Our Mission

We envision a world where mental health is simply health. It’s our mission to build accessible and impactful technology solutions to facilitate healing and well-being.

A Heart-Forward Team
Delivering Novel Solutions

Every one of our team members has a personal story of how mental health has affected their life, or that of a loved one. The team behind PsyAssist brings those life experiences, along with diverse expertise, worldviews, and skill sets.

Our Product Development Approach

Identify
 Foundational Research

Design & Testing

Validation

Collaboration Partners

Meet Our Advisors & Investors

Walter Greeleaf
PHD

Neuroscience Advisor

Steven Baumrucker
MD, FAAFP, FAAHPM

Chief Medical Advisor

Albert Rizzo
PHD

Neuroscience & Psychiatric Advisor

Partial Investor List

Partial Investor List

PsyAssist in the News

Tech Startup Tripp To Use Virtual Reality To Improve Psychedelic Therapy
by Natan Ponieman
TRIPP Wants You to ‘Be Here Now,’ With or Without Ram Dass
by Greg Gilman
No, VR Will Not Give You A Psychedelic Trip
by Zeus Tipado
Could a VR “TRIP” offer a sober shortcut to the healing potential of Psychedelics?
by Mellisa Pandika

PsyAssist App is not a replacement for psychotherapy or psychedelic-assisted psychotherapy. This is a supplementary tool offered to support patients who are being treated in a clinical setting.

Ketamine for Generalized Anxiety Disorder
Ketamine for Social Anxiety Disorder
Ketamine Administration for Chronic Posttraumatic Stress Disorder
Ketamine Effects on EEG during Therapy of Treatment-Resistant Generalized Anxiety and Social Anxiety
Safety and efficacy of maintenance ketamine treatment in patients with treatment-refractory generalised anxiety and social anxiety disorders
Remission from Chronic Anorexia Nervosa With Ketogenic Diet and Ketamine
Effects of Ketamine in Treatment-Refractory Obsessive-Compulsive Disorder
Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression
Ketamine Reduces Alcohol Consumption in Hazardous Drinkers by Interfering with the Reconsolidation of Drinking Memories
A sub-set of psychoactive effects may be critical to the behavioral impact of Ketamine on cocaine use disorder
Ketamine psychotherapy for heroin addiction: immediate effects and two-year
follow-up
‍Efficacy of Ketamine in the Treatment of Substance Use Disorders: A Systematic Review
Ketamine in Treating Depression
Ketamine in Treating PTSD
Ketamine in Treating Anxiety
Psilocybin for treatment-resistant depression
Psychedelic drugs
Psilocybin-Assisted Therapy
Psilocybin Therapeutic Research
MDMA-assisted therapy for severe PTSD
MDMA for  treatment of chronic posttraumatic stress disorder
MDMA-Assisted Therapy for the Treatment of Social Anxiety in Autistic Adults
A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy
The hidden therapist: evidence for a central role of music in psychedelic therapy
A problem was detected in the following Form. Submitting it could result in errors. Please contact the site administrator.
Waitlist
Get exclusive access to PsyAssist Beta for your clinic.
What best describes your clinical practice?

Be amongst the first to test the PsyAssist mobile app.
Would you like your care provider to offer PsyAssist?
Please enter their information and we will reach out to them. (Optional)
Device Type
Participate in our clinical research for early access.